Operating microscope use during alveolar ridge preservation tied to granulomatous tissue removal and improved healing ...

The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease. However, researchers have now shown that there is a risk of inadvertently ...

In this case, the patient does not have features fully consistent with a diagnosis of Crohn's disease. The presentation is more in keeping with a diagnosis of ileitis of spondylarthropathy. It can ...

The CRISPR molecular scissors have the potential to revolutionize the treatment of genetic diseases. This is because they can ...

We provide a brief description of NAID and we review main pathogenetic and clinical aspects behind a positioning of CD, in autoinflammatory granulomatous diseases. The three-domains structure of the ...

The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease.

The research team has now succeeded in using the CRISPR system to insert the missing letters in the right place. They ...

Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo treatments capable of precisely and durably engineering the hematopoietic system, today unveiled its ...

Oct. 31, 2024 — Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called ...

POD is an inflammatory facial eruption, presenting as tiny monomorphic flesh-colored to erythematous papules, vesicles, or pustules around the mouth (see Figure 1), and in some cases involving the ...

This is because they can be used to correct specific defective sections of the genome. Unfortunately, however, there is a catch: under certain conditions, the repair can lead to new genetic defects – ...

Histopathology was varied and included classical orbital pseudotumour (9/24), sclerosing orbital pseudotumour (13/24), vasculitic orbital pseudotumour (1/24) and granulomatous orbital pseudotumour ...